BeiGene, Ltd.

About BeiGene, Ltd.

BeiGene, Ltd. is a global biotechnology company focused on discovering and developing innovative medicines for the treatment of cancer. Founded in 2010, the company has rapidly grown to become a leader in the biopharmaceutical industry, with a commitment to advancing the science of oncology.

At BeiGene, we are dedicated to improving patient outcomes through our robust pipeline of targeted therapies and immuno-oncology treatments. Our research and development efforts are driven by a team of world-class scientists and clinicians who are passionate about making a difference in the lives of patients.

We operate with a strong emphasis on collaboration, partnering with leading academic institutions and other biopharmaceutical companies to accelerate the development of new therapies. Our state-of-the-art facilities are equipped with cutting-edge technology, enabling us to conduct advanced research and clinical trials.

Our vision is to provide access to high-quality, affordable medicines for patients around the world. We believe that every patient deserves the best possible care, and we strive to make our therapies accessible to those in need.

In addition to our focus on innovation, BeiGene is committed to sustainability and corporate responsibility. We actively engage in initiatives that promote environmental stewardship and community support.

• Core Activities: Research and development of cancer therapies
• Vision: Improving patient outcomes globally
• Commitment: Access to affordable medicines

With headquarters in the UK, BeiGene continues to expand its global presence, aiming to bring hope to patients facing cancer through groundbreaking treatments.